Human Genetics

, Volume 125, Issue 3, pp 265–279 | Cite as

New genetic evidence for involvement of the dopamine system in migraine with aura

  • Unda Todt
  • Christian Netzer
  • Mohammad Toliat
  • Axel Heinze
  • Ingrid Goebel
  • Peter Nürnberg
  • Hartmut Göbel
  • Jan Freudenberg
  • Christian Kubisch
Original Investigation

Abstract

In order to systematically test the hypothesis that genetic variation in the dopamine system contributes to the susceptibility to migraine with aura (MA), we performed a comprehensive genetic association study of altogether ten genes from the dopaminergic system in a large German migraine with aura case-control sample. Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes—DBH, DRD2 and SLC6A3—were chosen to proceed to additional genotyping of 380 MA cases and 378 controls. Four of the 26 genotyped polymorphisms in these three genes displayed nominally significant allelic P-values in the sample of 650 MA patients and 650 controls. Three of these SNPs [rs2097629 in DBH (uncorrected allelic P value = 0.0012, OR = 0.77), rs7131056 in DRD2 (uncorrected allelic P value = 0.0018, OR = 1.28) and rs40184 in SLC6A3 (uncorrected allelic P value = 0.0082, OR = 0.81)] remained significant after gene-wide correction for multiple testing by permutation analysis. Further consideration of imputed genotype data from 2,937 British control individuals did not affirm the association with DRD2, but supported the associations with DBH and SLC6A3. Our data provide new evidence for an involvement of components of the dopaminergic system—in particular the dopamine-beta hydroxylase and dopamine transporter genes—to the pathogenesis of migraine with aura.

Supplementary material

439_2009_623_MOESM1_ESM.doc (47 kb)
Supplementary material 1 (DOC 47 kb)

References

  1. Akerman S, Goadsby PJ (2007) Dopamine and migraine: biology and clinical implications. Cephalalgia 27:1308–1314PubMedCrossRefGoogle Scholar
  2. Arinami T, Gao M, Hamaguchi H, Toru M (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6:577–582PubMedCrossRefGoogle Scholar
  3. Asuni C, Cherchi A, Congiu D, Piccardi MP, Del Zompo M, Stochino ME (2007) Association study between clinical response to rizatriptan and some candidate genes. J Headache Pain 8:185–189PubMedCrossRefGoogle Scholar
  4. Cader ZM, Noble-Topham S, Dyment DA, Cherny SS, Brown JD, Rice GP, Ebers GC (2003) Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet 12:2511–2517PubMedCrossRefGoogle Scholar
  5. Cardon LR, Abecasis GR (2003) Using haplotype blocks to map human complex trait loci. Trends Genet 19:135–140PubMedCrossRefGoogle Scholar
  6. Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009–1013PubMedCrossRefGoogle Scholar
  7. D’Souza UM, Craig IW (2006) Functional polymorphisms in dopamine and serotonin pathway genes. Hum Mutat 27:1–13PubMedCrossRefGoogle Scholar
  8. de Sousa SC, Karwautz A, Wober C, Wagner G, Breen G, Zesch HE, Konrad A, Zormann A, Wanner C, Kienbacher C, Collier DA, Wober-Bingol C (2007) A dopamine D4 receptor exon 3 VNTR allele protecting against migraine without aura. Ann Neurol 61:574–578PubMedCrossRefGoogle Scholar
  9. Del Zompo M (2000) Dopaminergic hypersensitivity in migraine: clinical and genetic evidence. Funct Neurol 15(Suppl 3):163–170PubMedGoogle Scholar
  10. Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781–786PubMedGoogle Scholar
  11. Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55:997–1004PubMedCrossRefGoogle Scholar
  12. Dichgans M, Forderreuther S, Deiterich M, Pfaffenrath V, Gasser T (1998) The D2 receptor NcoI allele: absence of allelic association with migraine with aura. Neurology 51:928PubMedGoogle Scholar
  13. Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115–121PubMedCrossRefGoogle Scholar
  14. Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths LR (2006) Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 251:118–123PubMedCrossRefGoogle Scholar
  15. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152–156PubMedGoogle Scholar
  16. Greenwood TA, Kelsoe JR (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511–520PubMedCrossRefGoogle Scholar
  17. Guan Y, Stephens M (2008) Practical issues in imputation-based association mapping. PLoS Genet 4:e1000279PubMedCrossRefGoogle Scholar
  18. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn Cephalalgia 24 (Suppl 1): 9–160Google Scholar
  19. International_HapMap_Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320CrossRefGoogle Scholar
  20. Karwautz A, Campos de Sousa S, Konrad A, Zesch HE, Wagner G, Zormann A, Wanner C, Breen G, Ray M, Kienbacher C, Natriashvili S, Collier DA, Wober C, Wober-Bingol C (2008) Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without aura. J Neural Transm 115:91–95PubMedCrossRefGoogle Scholar
  21. Lao O, Lu TT, Nothnagel M, Junge O, Freitag-Wolf S, Caliebe A, Balascakova M, Bertranpetit J, Bindoff LA, Comas D, Holmlund G, Kouvatsi A, Macek M, Mollet I, Parson W, Palo J, Ploski R, Sajantila A, Tagliabracci A, Gether U, Werge T, Rivadeneira F, Hofman A, Uitterlinden AG, Gieger C, Wichmann HE, Ruther A, Schreiber S, Becker C, Nurnberg P, Nelson MR, Krawczak M, Kayser M (2008) Correlation between genetic and geographic structure in Europe. Curr Biol 18:1241–1248PubMedCrossRefGoogle Scholar
  22. Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 3:35–40PubMedGoogle Scholar
  23. Maude S, Curtin J, Breen G, Collier D, Russell G, Shaw D, Clair DS (2001) The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson’s disease. Psychiatr Genet 11:49–52PubMedCrossRefGoogle Scholar
  24. McCallum LK, Fernandez F, Quinlan S, Macartney DP, Lea RA, Griffiths LR (2007) Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility. Eur J Neurol 14:706–707PubMedCrossRefGoogle Scholar
  25. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP (2001) The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79:1033–1038PubMedCrossRefGoogle Scholar
  26. Mill J, Asherson P, Craig I, D’Souza UM (2005) Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet 6:3PubMedCrossRefGoogle Scholar
  27. Miller GM, Madras BK (2002) Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7:44–55PubMedCrossRefGoogle Scholar
  28. Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, Montagna P (2003) A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci 23:301–305PubMedCrossRefGoogle Scholar
  29. Nahmias J, Burley MW, Povey S, Porter C, Craig I, Wolfe J (1992) A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus. Hum Mol Genet 1:286PubMedCrossRefGoogle Scholar
  30. Netzer C, Todt U, Heinze A, Freudenberg J, Zumbroich V, Becker T, Goebel I, Ohlraun S, Goebel H, Kubisch C (2006) Haplotype-based systematic association studies of ATP1A2 in migraine with aura. Am J Med Genet B Neuropsychiatr Genet 141B:257–260PubMedCrossRefGoogle Scholar
  31. Netzer C, Freudenberg J, Heinze A, Heinze-Kuhn K, Goebel I, McCarthy LC, Roses AD, Gobel H, Todt U, Kubisch C (2008a) Replication study of the insulin receptor gene in migraine with aura. Genomics 91:503–507PubMedCrossRefGoogle Scholar
  32. Netzer C, Freudenberg J, Toliat MR, Heinze A, Heinze-Kuhn K, Thiele H, Goebel I, Nurnberg P, Ptacek LJ, Gobel H, Todt U, Kubisch C (2008b) Genetic association studies of the chromosome 15 GABA-A receptor cluster in migraine with aura. Am J Med Genet B Neuropsychiatr Genet 147B:37–41PubMedCrossRefGoogle Scholar
  33. Noble EP (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 116B:103–125PubMedCrossRefGoogle Scholar
  34. Palotie ABR, Wessman M (2002) Migraine. In: King RARJ, Motulsky AG (eds) The Genetic Basis of common diseases. Oxford University Prss, Oxford, pp 935–947Google Scholar
  35. Payseur BA, Place M, Weber JL (2008) Linkage disequilibrium between STRPs and SNPs across the human genome. Am J Hum Genet 82:1039–1050PubMedCrossRefGoogle Scholar
  36. Peroutka SJ (1997) Dopamine and migraine. Neurology 49:650–656PubMedGoogle Scholar
  37. Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201–206PubMedGoogle Scholar
  38. Peroutka SJ, Price SC, Wilhoit TL, Jones KW (1998) Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4:14–21PubMedGoogle Scholar
  39. Porter CJ, Nahmias J, Wolfe J, Craig IW (1992) Dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase (DBH) locus. Nucleic Acids Res 20:1429PubMedCrossRefGoogle Scholar
  40. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150PubMedCrossRefGoogle Scholar
  41. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575PubMedCrossRefGoogle Scholar
  42. Rebaudengo N, Rainero I, Parziale A, Rosina F, Pavanelli E, Rubino E, Mazza C, Ostacoli L, Furlan PM (2004) Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia 24:503–507PubMedCrossRefGoogle Scholar
  43. Russell MB, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. Bmj 311:541–544PubMedGoogle Scholar
  44. Schaid DJ (2004) Evaluating associations of haplotypes with traits. Genet Epidemiol 27:348–364PubMedCrossRefGoogle Scholar
  45. Shepherd AG, Lea RA, Hutchins C, Jordan KL, Brimage PJ, Griffiths LR (2002) Dopamine receptor genes and migraine with and without aura: an association study. Headache 42:346–351PubMedCrossRefGoogle Scholar
  46. Sicuteri F (1977) Dopamine, the second putative protagonist in headache. Headache 17:129–131PubMedCrossRefGoogle Scholar
  47. Stochino ME, Asuni C, Congiu D, Del Zompo M, Severino G (2003) Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes. Pharmacol Res 48:531–534PubMedCrossRefGoogle Scholar
  48. Tang Y, Buxbaum SG, Waldman I, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF (2006) A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 60:1034–1038PubMedCrossRefGoogle Scholar
  49. Todt U, Freudenberg J, Goebel I, Heinze A, Heinze-Kuhn K, Rietschel M, Gobel H, Kubisch C (2006) Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura. Neurology 67:1707–1709PubMedCrossRefGoogle Scholar
  50. Wei J, Ramchand CN, Hemmings GP (1997) Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 99:52–55PubMedCrossRefGoogle Scholar
  51. Wellcome_Trust_Case_Control_Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRefGoogle Scholar
  52. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelernter J, Cubells JF (2001) A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515–522PubMedCrossRefGoogle Scholar
  53. Zhang K, Qin ZS, Liu JS, Chen T, Waterman MS, Sun F (2004) Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res 14:908–916PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Unda Todt
    • 1
    • 2
    • 3
  • Christian Netzer
    • 1
    • 2
    • 3
  • Mohammad Toliat
    • 2
    • 4
  • Axel Heinze
    • 6
  • Ingrid Goebel
    • 1
    • 2
    • 3
  • Peter Nürnberg
    • 2
    • 4
    • 5
  • Hartmut Göbel
    • 6
  • Jan Freudenberg
    • 7
  • Christian Kubisch
    • 1
    • 2
    • 3
    • 5
  1. 1.Institute of Human GeneticsUniversity of CologneCologneGermany
  2. 2.Institute for GeneticsUniversity of CologneCologneGermany
  3. 3.Center for Molecular MedicineUniversity of CologneCologneGermany
  4. 4.Cologne Center for GenomicsUniversity of CologneCologneGermany
  5. 5.Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD)University of CologneCologneGermany
  6. 6.Kiel Pain and Headache CentreKielGermany
  7. 7.Center for Genomics and Human Genetics, Feinstein Institute for Medical ResearchNorthshore-LIJ University HospitalNew YorkUSA

Personalised recommendations